The tripeptide enters cells via PepT1 transporter and reduces pro-inflammatory cytokine secretion in intestinal epithelial cells and macrophages[14]
Beyond cosmetics, research has explored GHK-Cu's potential in therapeutic wound healing (chronic wounds, surgical recovery, diabetic ulcers), hair restoration, tissue engineering, nerve regeneration, lung disease, and even systemic anti-aging interventions
Critics argue that the FDA's caution could restrict access to a potentially beneficial compound, advocating for a more balanced approach that considers BPC-157's therapeutic potential
While clinical studies have explored its use in topical skincare and wound care, the 100mg formulation provides a high-concentration, cost-effective foundation for longitudinal studies, dose-response curves, and combination protocols particularly when paired with BPC-157 or TB-500
Formulated in a stabilized pre-mixed injection pen for SubQ administration , GHK-Cu ensures high systemic bioavailability and precise dosing control under research conditions
Nature, 445(7124), 177-182